Literature DB >> 18063100

Comparison of three adjuvants used to produce polyclonal antibodies to veterinary drugs.

Terence L Fodey1, Philippe Delahaut, Caroline Charlier, Christopher T Elliott.   

Abstract

Two commercially available adjuvants, Gerbu LQ 3000 and Montanide ISA 50V, were assessed as potential replacements for Freund's adjuvant by evaluating their efficacy in the production of polyclonal antibodies to veterinary drugs in rabbits. The aim was to find an adjuvant that could produce a similar (or enhanced) immune response in the host animal without the undesirable side effects associated with Freund's complete and incomplete adjuvant. The assessment involved the examination of each injection site and the characterisation of the resultant antibodies with regards to antibody titre and sensitivity. It was found that the rabbits immunised with Gerbu adjuvant produced some of the most sensitive antibodies. However, titres were relatively low and adverse effects at injection sites were relatively common. Montanide adjuvant produced no adverse effects and the related antibodies were found to be of adequate sensitivity when compared to those from rabbits immunised with Freund's. It was concluded that Montanide ISA 50V could be considered as a suitable replacement to Freund's for the production of polyclonal antibodies, to low molecular weight compounds in rabbits.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18063100     DOI: 10.1016/j.vetimm.2007.10.016

Source DB:  PubMed          Journal:  Vet Immunol Immunopathol        ISSN: 0165-2427            Impact factor:   2.046


  6 in total

1.  Protective effect of a prime-boost strategy with the Ts87 vaccine against Trichinella spiralis infection in mice.

Authors:  Yuan Gu; Bin Zhan; Yaping Yang; Xiaodi Yang; Xi Zhao; Lei Wang; Jing Yang; Kuo Bi; Yunyun Wang; Xinping Zhu
Journal:  Biomed Res Int       Date:  2014-08-28       Impact factor: 3.411

2.  Gut-Associated Lymphoid Tissue: A Key Tissue Inside the Mucosal Immune System of Hens Immunized with Escherichia coli F4.

Authors:  Maria F Peralta; Alejandra Magnoli; Fabrisio Alustiza; Armando Nilson; Raúl Miazzo; Adriana Vivas
Journal:  Front Immunol       Date:  2017-05-22       Impact factor: 7.561

Review 3.  Vaccines, adjuvants and autoimmunity.

Authors:  Luísa Eça Guimarães; Britain Baker; Carlo Perricone; Yehuda Shoenfeld
Journal:  Pharmacol Res       Date:  2015-08-12       Impact factor: 7.658

4.  Production of polyclonal antibody against kidney antigens: a model for studying autoantibody in feline chronic kidney diseases.

Authors:  Nisakorn Songaksorn; Wilaiwan Petsophonsakul; Kidsadagon Pringproa; Kannika Na Lampang; Nattawooti Sthitmatee; Nuttawan Sriphawattana; Kriangkrai Thongkorn
Journal:  J Vet Sci       Date:  2019-11       Impact factor: 1.672

5.  Fowl adenovirus (FAdV) fiber-based vaccine against inclusion body hepatitis (IBH) provides type-specific protection guided by humoral immunity and regulation of B and T cell response.

Authors:  Carlotta De Luca; Anna Schachner; Taniya Mitra; Sarah Heidl; Dieter Liebhart; Michael Hess
Journal:  Vet Res       Date:  2020-12-02       Impact factor: 3.683

6.  Protective immunity against Trichinella spiralis infection induced by a multi-epitope vaccine in a murine model.

Authors:  Yuan Gu; Junfei Wei; Jing Yang; Jingjing Huang; Xiaodi Yang; Xinping Zhu
Journal:  PLoS One       Date:  2013-10-10       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.